INTRODUCTION
============

22q11.2 Microdeletion Syndrome (22q11DS; also known as Velocardiofacial syndrome or DiGeorge Syndrome) is a neurogenetic disorder that carries significantly increased risk for developing psychosis ([@B89]; [@B75]; [@B35]; [@B37]; [@B101]). One prevailing model of psychosis pathogenesis is that of a 'developmental disconnection' syndrome, whereby genetic and neurodevelopmental influences lead to structural abnormalities in brain regions critical for cerebral communication ([@B48]). This dysconnectivity may be particularly salient during adolescence given that the brain is still developing, which may be related to the emergence of psychotic symptoms in vulnerable individuals ([@B81]). Thus, studying adolescents and young adults with 22q11DS, a highly penetrant disorder with well-defined genetic etiology, can help us understand how structural dysconnectivity affects a complex psychiatric phenotype (i.e., psychosis).

Diffusion weighted imaging (DWI), which measures the diffusion patterns of water molecules in brain tissue, offers a method to examine structural connectivity between brain regions ([@B74]). Specifically, fractional anisotropy (FA), a measure derived from diffusion tensor imaging (DTI), indicates the directionality and density of the fiber tracts in a voxel, and has been traditionally viewed as a measure of white matter or myelin integrity ([@B123]). FA values are calculated based on the ratio of the longest to shortest axes of diffusion, and values fall between zero and one: zero indicates that the diffusion is isotropic, or unrestricted in all directions, indicating an absence of organized fiber tracts to constrain directionality. A value closer to one means that diffusion occurs more strongly along one axis, suggesting increased fiber organization and white matter integrity. FA is a standard measure of "white matter integrity," but other DTI indices, such as axial diffusivity (AD) and radial diffusivity (RD), may be more informative regarding the specific nature of the white matter dysfunction ([@B1]). For example, AD is a measure of diffusivity along the principal axis, and decreases in AD have been linked with greater axonal damage in rodents ([@B115]; [@B13], [@B14]). RD is an average of the measures of the diffusivities in the two minor axes, and is thought to index the amount of space between axons; accordingly, increased RD has been associated with demyelination in animal models ([@B116], [@B115], [@B117]). These explanations for FA, AD, and RD are generally accepted, but there may be alternative interpretations regarding the underlying white matter microstructure, particularly where fibers cross ([@B62]; [@B130]). Studying these three indices within a 22q11DS sample and examining their relationships with psychotic symptoms may reveal important information about mechanistic brain changes relevant to the development of psychosis.

Since DTI was introduced in 1994, there have been over 200 articles published on DTI and idiopathic schizophrenia. These studies have revealed disrupted white matter integrity (i.e., FA reductions) in multiple white matter tracts across the phases of illness, including individuals at clinical high-risk (CHR) for psychosis ([@B47]; [@B11]; [@B16]), first-episode ([@B83]; [@B88]; [@B65]; [@B60]), chronically ill ([@B29]; [@B57]), and medication-naïve schizophrenia patients ([@B38]; [@B42]; [@B64]). The most consistently reported abnormalities are in fronto-temporal and fronto-limbic tracts ([@B24]; [@B58]; [@B95]), including the superior longitudinal fasciculus (SLF; [@B121]; [@B20]), one of the largest long-range fiber tracts in the brain which connects the parietal to frontal lobes, and the uncinate fasciculus ([@B15]; [@B120]; [@B51]; [@B55]), a tract which connects regions of the limbic system with orbitofrontal cortex. Increased RD may drive global FA reductions in schizophrenia ([@B105]; [@B60]; [@B99]; [@B27]) findings which are supported by the post-mortem histopathology literature, which indicates disturbances in the function and structure of oligodendrocytes ([@B23]; [@B128]), brain cells responsible for the myelination of axons.

A recent review of the existing literature on anomalous white matter development associated with schizophrenia proposes a model that combines the influence of both neurodevelopmental and neuroprogressive influences on white matter in schizophrenia ([@B84]). In this model, both early disruption of white matter development, particularly during adolescence, paired with later white matter microstructural changes due to disease chronicity, medication effects, or later onset progressive changes result in the white matter abnormalities seen in schizophrenia ([@B84]). Regarding disruption of white matter during adolescence, [@B47], found that youth at clinical high risk for developing psychosis failed to show the typical age-associated increased of FA in the medial temporal lobe in comparison to typically developing controls. There is preliminary evidence that 22q11DS participants also show a disrupted trajectory of white matter development; one research group found that an overall measure of total mean FA increased in controls, but that this relationship was not observed in 22q11DS participants ([@B79]). However, age-associated disruptions in 22q11DS have not been examined in specific white matter tracts.

While many studies have shown that decreased FA is associated with cognitive functioning in patients with idiopathic schizophrenia ([@B129]; [@B64]; [@B76]; [@B93]), to our knowledge only one DTI study of CHR youth has examined the relationship between DTI measures and social processes. In this longitudinal study, lower FA in the medial temporal lobe and inferior longitudinal fasciculus (ILF) predicted a drop in social functioning in CHR participants 15 months later ([@B47]). Given that many brain regions affected in schizophrenia are also implicated in social cognition ([@B87]) and a prior study by our laboratory found that a measure of social cognition (Theory of Mind) was the most significant predictor of psychotic symptoms in 22q11DS ([@B44]), we aimed to examine whether white matter microstructural integrity is linked to social-cognitive dysfunction in 22q11DS.

As in idiopathic schizophrenia and those at clinical high risk, white matter integrity may also be disrupted in multiple brain regions in 22q11DS, but findings are mixed. Three cross-sectional studies of children with 22q11DS found lower FA in the SLF ([@B7]; [@B119]; [@B125]), complementing existing schizophrenia findings ([@B25]; [@B121]; [@B47]; [@B20]). The largest existing DTI study of 22q11DS to date (33 22q11DS and 16 unaffected siblings, mean age: 18.0 years), found bilateral FA reductions in the uncinate fasciculus ([@B91]), which is also consistent with the idiopathic schizophrenia literature ([@B15]; [@B120]; [@B51]; [@B55]). Lower FA in the ILF and splenium of the corpus callosum has also been observed in both 22q11DS ([@B125]) and idiopathic schizophrenia ([@B30]; [@B64]). In adults with 22q11DS, disruption in other white matter tracts has been observed in multiple brain regions, including the parietal ([@B22]; [@B52]) and parahippocampal regions ([@B22]). Preliminary evidence suggests that white matter microstructural abnormalities in 22q11DS may be driven by reduced axonal coherence ([@B52], [@B53]; [@B91]).

However, other studies have found that, compared to healthy controls, 22q11DS participants have *increased* FA in the splenium and genu of the corpus callosum ([@B7]; [@B119]), the inferior fronto-occipital fasciculus (IFO) and SLF ([@B112]) and portions of the corona radiata ([@B119]). These studies did not investigate the component measures that comprise FA (AD and RD), so it is not clear what was contributing to these increases. Additionally, given that most current publications have \<20 patients in their sample, larger sample sizes are warranted, in order to clarify the nature of white matter pathology in 22q11DS.

Notably, there is some evidence for a relationship between white matter integrity and social behavior in 22q11DS. Specifically, in a combined analysis of 22q11DS participants and controls, increased AD in the posterior corona radiata, SLF, and IFO was related to better social skills ([@B91]). Additionally, reduced FA in frontal, cingulate, and temporal regions was associated with increased psychotic symptom severity in adults with 22q11DS ([@B22]). However, no study has simultaneously examined laboratory-based measures of social cognition (e.g., Theory of Mind, emotion recognition) and psychotic symptoms and their relationship to DTI measures in individuals with 22q11DS.

Our study had three main goals: (1) to examine group differences between 22q11DS participants and controls on multiple DTI measures (e.g., FA, AD, and RD) via a whole-brain and ROI-based approach; (2) to explore where there are age-associated disruptions in these DTI metrics in 22q11DS patients versus typically developing controls, and (3) to relate positive symptoms and social cognition performance to measures of white matter microstructure in 22q11DS and controls. First, based on prior work ([@B119]; [@B91]), we expected to find lower FA in long-range fiber tracts in 22q11DS relative to controls, including the SLF and uncinate fasciculus, which would be driven by abnormal AD ([@B52]; [@B91]). Based on previous literature in CHR youth and 22q11DS ([@B47]; [@B79]), we hypothesized that 22q11DS youth would fail to show the typical age-associated increases in FA observed in typically developing controls ([@B111]). We also hypothesized that integrity of the uncinate fasciculus, a fronto-limbic white matter tract relevant to social cognition and previously shown to be disrupted in both patients with 22q11DS and idiopathic schizophrenia ([@B7]; [@B120]), would be associated with positive symptom severity and social cognition in 22q11DS.

MATERIALS AND METHODS {#s1}
=====================

PARTICIPANTS
------------

The initial sample consisted of 76 participants (10--26 years old, 40 22q11DS, and 36 controls). DTI data from 11 participants (4 22q11DS, 7 controls) were excluded due to poor image quality or severe motion/scanning artifacts. Thus, the final sample consisted of 65 participants (36 22q11DS, 29 controls, **Table [1](#T1){ref-type="table"}**).

###### 

Demographic and clinical characteristics of study participants.

                                                                       22q11.2 Microdeletion Syndrome (22q11DS) Participants (*n* = 36)   Healthy Comparison Participants (*n* = 29)   
  -------------------------------------------------------------------- ------------------------------------------------------------------ -------------------------------------------- --------------
  Age (years, ±SD)                                                     16.3 (4.3)                                                         15.5 (3.8)                                   *p* = 0.46
  Participant Education (years, ±SD)                                   9.2 (3.3)                                                          9.4 (3.9)                                    *p* = 0.78
  Parental Education (years, ±SD)                                      16.3 (2.3)                                                         15.5 (3.1)                                   *p* = 0*.25*
  Gender (*N*, % female)                                               25 (69%)                                                           14 (48%)                                     *p* = 0.14
  Race (Asian/African American/Caucasian/Multiple)                     0/1/32/3                                                           1/3/20/5                                     *p* = 0.21
                                                                                                                                                                                       
  Psychotic Disorder Diagnosis (*N*, %)                                4 (11%)                                                            NA                                           
  SIPs Positive Symptoms (mean, ±SD)                                   6.6 (7.1)                                                          0.7 (1.3)                                    *p* \< 0.001
  SIPs Negative Symptoms                                               8.1 (6.3)                                                          1.0 (1.8)                                    *p* \< 0.001
  SIPs Disorganized Symptoms                                           4.6 (4.8)                                                          0.5 (0.9)                                    *p* \< 0.001
  SIPs General Symptoms                                                4.9 (5.0)                                                          0.9 (1.4)                                    *p* \< 0.001
  Psychotropic Medication (*N*, None/Antipsychotics/Antidepressants)   26/4/6                                                             NA                                           
  WASI IQ Score                                                        78.1 (14.8)                                                        107.4 (17.6)*^a^*                            *p* \< 0.001

a

IQ score available for 27 controls.

22q11DS participants all had a molecularly confirmed diagnosis of 22q11.2 deletion syndrome and were recruited from an ongoing longitudinal study at the University of California, Los Angeles (UCLA). Typically developing healthy controls were also recruited from this study. Exclusion criteria for all study participants were: neurological or medical condition disorder that might affect performance, insufficient fluency in English, and/or if they endorsed substance or alcohol abuse and/or dependence within the past six months. Controls also must not meet criteria for any major mental disorder, with the exception of attention deficit-hyperactivity disorder (ADHD) or past episode of depression, based on information gathered during the Structured Clinical Interview for DSM-IV Axis I Disorders ([@B26]). Three controls in our sample had a past single episode of depression, and none of our controls had a diagnosis of ADHD. We did not exclude 22q11DS patients with comorbid medical conditions, given that these conditions are characteristic of the disorder.

All participants gave verbal and written informed consent. Participants under the age of 18 years provided written assent, while their parent or guardian completed written consent. The UCLA Institutional Review Board (IRB) approved all study procedures and informed consent documents.

MEASURES
--------

### Structured interview for prodromal syndromes

A master's level trained clinician assessed all participants on the positive, negative, disorganized, and general symptom scales from the Structured Interview for Prodromal Syndromes (SIPS, [@B70]). Symptoms on these scales are rated from 0 to 6, with zero representing an absence of symptoms and six referring to an extremely severe level of symptoms. This measure has shown excellent inter-rater reliability ([@B72]; [@B71]). All raters demonstrated good to excellent inter-rater reliability for symptom ratings, with kappa values ranging from 0.85 to 1.00. For the purposes of this study, we used the sum of the positive SIPS symptom scores as a dimensional measure of psychotic symptom severity. This measure encompasses a range of symptom severity, including sub-threshold (prodromal), and fully psychotic symptoms.

### Social cognition tasks

Study participants received the Penn Emotion Recognition Test (ER40), a computerized emotion identification task in which 40 color photographs of adult faces, varying in race and gender, are randomly presented ([@B56]). Participants were asked to identify the emotion of each face (happy, sad, anger, fear, or no emotion) and were given as long as needed to respond (total maximum score = 40, each emotion presented eight times). This measure has shown adequate construct validity and test--retest reliability ([@B17]), and has been previously used with adolescents ([@B100]; [@B94]) and 22q11DS participants ([@B34]; [@B39]).

All participants were administered Part 3 of The Awareness of Social Inference Test (TASIT; [@B69]). The TASIT is a computerized task believed to assess one's ability to comprehend the intentions of others, particularly how one comprehends white lies or sarcasm. The task consists of 16 vignettes (each lasting between 15 and 60 s), eight of which show an individual telling a lie, while the other eight display an interaction in which someone uses sarcasm. After viewing each vignette, an assessor asked the participant four questions related to the scene: (1) what someone is doing to another person in the scene, (2) what someone is trying to say to the other person, (3) what one of the individuals in the scene is thinking, and (4) what one of the characters in the vignette is feeling. After task completion, an overall score was calculated (maximum = 64). The TASIT has shown adequate reliability and validity with brain-injured patients ([@B68]), and has been used with adolescents at CHR for psychosis, along with first-episode and chronic patients with schizophrenia ([@B36]).

IMAGE ACQUISITION
-----------------

All scanning was carried out on an identical Siemens 3 Tesla Tim Trio MRI scanner at either the UCLA Brain Mapping Center (BMC; 22q11DS = 15, controls = 16) or at the Center for Cognitive Neuroscience (CCN; 22q11DS = 21, controls = 13). The age distribution for both 22q11DS patient and control subjects did not differ across scanner locations. There were, however, significantly more female 22q11DS participants compared to controls scanned at the CCN (*p* = 0.009); however, the gender distribution was similar for all other comparisons (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). DTI and structural MRI protocols were identical at both scanner locations. Specifically, measures of brain structure were obtained using T1-weighted anatomical images acquired with an MPRAGE sequence with the following acquisition parameters: TR/TE/TI = 2300/2.91/900; flip angle = 9°; slice thickness = 1.20 mm, with a 240 × 256 acquisition matrix. A diffusion-weighted, spin-echo echo-planar imaging scan was collected using these parameters: 64 diffusion gradient directions, TR/TE = 7100/93 ms; FOV = 190 mm × 190 mm; 96 × 96 matrix; slice thickness = 2.0 mm; b-value = 1000 s/mm^2^ and one non-diffusion sensitized volume was also acquired (*b*-value = 0/s/mm^2^), which we will call the *b*0 image.

IMAGE ANALYSIS
--------------

The T1-weighted images were skull-stripped using Brainsuite's surface extraction tool (BSE), and then manually edited to remove any remaining non-brain tissue. The skull-stripped T1 images were then linearly aligned using FSL's "FLIRT" (with 6 degrees of freedom) to a common space (MNI-ICBM 152 non-linear sixth generation) with 1mm isotropic voxels and a 182 × 182 × 182 voxel matrix. For the DWI scans, we removed non-brain regions from the T2-weighted weighted *b0* image with FSL's brain extraction tool (BET) and the resulting mask was then applied to the remaining 64 volumes. We then corrected the images for eddy current distortion by using FSL's eddy correct tool. The original gradient vectors were rotated using the linear rotation and translation matrix. Then, each individual's eddy corrected DWI volumes were linearly aligned (9 degrees of freedom) to the corresponding skullstripped T1 image in the MNI-ICBM 152 standard space. The gradient vectors were once more adjusted by using the resulting linear rotation and translation matrix of this transformation. To compensate for EPI-induced susceptibility artifacts, the *b0* image was non-linearly registered in three directions to the T1 structural scan in the MNI-ICBM 152 space ([@B61]), by using an elastic regularizer (with a weight of 0.0001) and a cost function based on mutual information. We then applied the derived non-linear vector fields to each of the 64 diffusion-weighted volumes. We then fit diffusion tensors at each voxel in the EPI-corrected DWI volumes by subject using DTIFit (FMRIB's Diffusion Toolbox). Tensor derived indices such as FA, AD, and RD, were then calculated for the whole brain. We applied the least weighted squares regression for the tensor calculation, which does not rely upon the assumption of homoscedasticity, and has been suggested as a preferred method over an ordinary least squares approach, which is typically used ([@B46]).

Group maps were then created using FSL's Tract-Based Spatial Statistics (TBSS). TBSS is a rigorous registration approach, which is imperative for comparisons in which tract shape or volume is likely to differ between groups. Because our sample included children, we aligned each FA map to each other and identified the most representative scan from our sample, which was then used as the target image. All images were then aligned to the target FA image through non-linear registration. All images are merged into a single 4D image and non-linear registration is used to create an FA "skeleton" based on the center of all of the tracts common to the entire group. Data are then projected from the center of each subject's tracts onto the skeleton for group comparison. This method ensures that statistics are only applied in regions where data exist for all subjects, and maximizes the likelihood that the pooled data originate from the center of a tract in every subject.

To characterize group differences between 22q11DS and controls at the voxel-wise level, we first used a whole-brain based approach. In this approach, we were not restricted to specific areas of interest and could identify nuanced abnormalities that may be obscured by the examining only regions of interest (ROI). Given the variability in 22q11DS findings, we decided to first take an unbiased approach. We also implemented a ROI analysis to confirm our whole-brain analysis, identify age-associated changes in known white matter tracts between 22q11DS and controls, and determine whether DTI indices in specific tracts are related to psychotic symptoms and measures of social cognition in 22q11DS participants and controls.

For the ROI-based approach, 20 regions per hemisphere were identified and determined based on the John Hopkins University probabilistic tractography atlas (**Figure [1](#F1){ref-type="fig"}**; [@B127]; [@B73]) and then customized based on the TBSS skeleton for the current study. Each subject's FA, AD, and RD skeleton was masked using each of the ROIs. Then average FA, AD, and RD were calculated and extracted for that segment of the skeleton for each individual.

![**Regions of interest (ROIs) examined in this study.** These ROIs were obtained from the Johns Hopkins University Probabilistic Tractography atlas ([@B127]; [@B74]). UNC, uncinate fasciculus; ILF, inferior longitudinal fasciculus; IFO, inferior fronto-occipital fasciculus; SLF, superior longitudinal fasciculus; ATR, anterior thalamic radiations.](fnbeh-08-00393-g001){#F1}

STATISTICAL ANALYSES
--------------------

Statistical analyses were performed using SPSS software v. 21 (Chicago, IL, USA). Correction for multiple comparisons was conducted using publicly available R software ([@B90]; command p.adjust{stats}). We compared demographic characteristics between groups using independent samples *t*-tests for continuous variables and chi square test for categorical variables. To test for cross-scanner differences, for all DTI measurements we first conducted a univariate analysis of covariance (ANCOVA) for each identified region in each hemisphere, with scanner location as the between-group factor and group as a covariate.

### Whole-brain analyses

To compare FA, AD, and RD across the entire skeleton in 22q11DS participants vs. controls, we conducted a non-parametric permutation analysis using the 'randomize' tool in FSL. We performed 10,000 permutations using the Threshold Free Cluster Environment (TFCE), which is a rigorous method that identifies "clusters" in the data without having to predefine the clusters ([@B113]). Demeaned age and sex and scanner location were included in the model as covariates and group was identified as the between-groups subjects factor. We corrected for multiple comparisons using family-wise error rate (FWE).

### Region of interest analyses

All neuroanatomic measures were first examined for normality using the Kolmogorov--Smirnov and Shapiro--Wilk tests; none were found to violate the assumptions of normality. To compare putative indices of white matter integrity (FA), and its sub-components, AD and RD, respectively, in 22q11DS vs. controls, we conducted an ANCOVA for each identified region in each hemisphere, with diagnosis (22q11DS vs. control) as the between subjects factor and sex, age, and scanner location as covariates. For these analyses, due to the large number of comparisons (60), false discovery rate (FDR) *q*-values were estimated using R software.

### Age × diagnosis interactions

To address whether the relationship between age and DTI measures differed between groups, we first visually examined the scatterplots of age vs. all DTI measures. Being mindful of multiple comparisons, we only wished to conduct statistical tests where the data suggested a possible interaction effect. For any DTI measure for which visual inspection suggested an age^∗^group interaction we then added the age^∗^group interaction term to the original ANCOVA models (in addition to group, age, sex, and scanner location). This resulted in a total of six additional analyses: FA in bilateral regions of the ILF, and SLF, and RD in bilateral regions of the ILF. For any significant age^∗^group interaction, we followed up by examining Pearson correlations between age and the DTI measure within groups. Following a visual inspection of the age^∗^group interactions, we confirmed that the other regions did not show any significant interactions (all *p* \> 0.14). Additionally, we ran a Pearson correlation to examine the relationship between age and psychotic symptoms in the 22q11DS sample.

### Association of DTI measures with social cognition and clinical symptoms

To explore the relationships of DTI measures with positive symptoms and social cognition tasks, we conducted correlational analyses for regions that showed significant group differences between 22q11DS participants and controls. Residuals were calculated from each DTI variable examined, after regressing out the effects of age, sex, and scanner. We also calculated residuals for the clinical and social cognition variables, regressing out the effects of age, sex, and scanner location. Next, we conducted Pearson correlations (corresponding to partial correlations) between each neuroanatomic brain region and residualized total positive symptoms. Due to the restricted range of positive symptoms in controls, we conducted this analysis only in 22q11DS patients. These analyses were then repeated within each group (22q11DS participants and controls), to investigate the relationship between DTI indices and social cognition performance. FDR *q*-values were estimated using R software. In regions that showed significant relationships between DTI indices and social cognition variables, we conducted a secondary analysis in which we also regressed out the effects of global cognitive abilities (WASI IQ score) and re-ran the Pearson correlations.

In regions that showed a significant relationship with overall ER40 performance, we conducted secondary analyses, focusing on Pearson correlations between the DTI measure and performance on each individual emotion (happy, sad, fear, anger, no emotion), particularly since a previous publication from our laboratory showed differential impairment in emotion recognition performance in 22q11DS ([@B44]).

### Association between axial and radial diffusivities

It is known that RD and AD make up the measure of FA; however, it is not clear if these two measures are related to each other in white matter tracts of interest. To evaluate the relationship between measures of AD and RD in each group, we correlated the residuals (regressing out effects of age, scanner location, and sex) for each DTI AD variable with the residuals for the corresponding DT RD variable in 22q11DS patients and controls separately. To directly compare the strength of correlations between the two groups, a Fisher r-to-z transformation was conducted. FDR *q*-values were estimated using R software.

RESULTS
=======

As shown in **Table [1](#T1){ref-type="table"}**, 22q11DS patient and control groups did not significantly differ in any of the demographic factors (all *p-*values ≥0.14).

EFFECTS OF SCANNER LOCATION
---------------------------

We found that scanner location had a significant effect on multiple DTI measures, with significant *q*-values ranging from 0.04 to 0.000001 (see Supplementary Table [S2](#SM1){ref-type="supplementary-material"} for more detailed information). These effects were consistent across regions: FA was consistently higher and AD and RD consistently lower in ROI's showing group differences. As such, all ANCOVAs included scanner site as a covariate.

GROUP DIFFERENCES: WHOLE BRAIN RESULTS
--------------------------------------

Compared to typically developing controls, 22q11DS showed significantly higher FA in multiple regions (**Figure [2](#F2){ref-type="fig"}**). Most of these significant differences were in the right hemisphere, and included the posterior limb of the internal capsule and the superior and posterior corona radiata. FA was higher in 22q11DS subjects in the body of the corpus callosum and in a small region of the left SLF. In these analyses, compared to typically developing controls, 22q11DS did not show decreased FA in any regions. There were also widespread reductions in AD and RD in 22q11DS in comparison to typically developing controls (**Figure [3](#F3){ref-type="fig"}**). The body and splenium of the corpus callosum, bilateral regions of ATR, and bilateral portions of the SLF and ILF showed reductions in both AD and RD in 22q11DS. Reductions that were specific to AD (but not observed for measures of RD) in 22q11DS were found in the bilateral IFO, while reductions that were specific to RD in 22q11DS were in the left superior corona radiata and upper regions of the corticospinal tract. When we plotted the overall raw mean FA values for regions that showed significant differences between 22q11DS and controls in the whole-brain analysis (i.e., right posterior limb of the internal capsule, right superior and posterior corona radiata, body of corpus callosum, and a small portion of the left SLF), we saw that FA was consistently higher in 22q11DS participants than controls, regardless of age (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). Thus, the increased FA observed at the whole brain level in 22q11DS does not appear to be the result of an age × group interaction.

![**Multiple slices of brain regions in FSL showing results of whole-brain FA analysis, indicating FA increases in 22q11.2 Microdeletion Syndrome (22q11DS) vs. controls.** Results are shown in the axial view and overlaid on the standard FMRI58 FA template.](fnbeh-08-00393-g002){#F2}

![**Figure showing overlap between regions that have reduced axial diffusivity (AD) and radial diffusivity (RD) in 22q11DS.** Regions that share abnormalities in AD and RD are in yellow, regions that have reduced AD only are shown in pink, and regions that have reduced RD only are in blue. Results are shown overlaid on the standard FMRI58 FA template.](fnbeh-08-00393-g003){#F3}

GROUP DIFFERENCES: REGION OF INTEREST ANALYSES
----------------------------------------------

Results for analyses of group differences between 22q11DS vs. controls in measures of FA, AD, and RD within specific white matter tracts are presented in Supplementary Table [S3](#SM1){ref-type="supplementary-material"}. FA in the region of the left cingulum bundle proximal to the hippocampus was lower in 22q11DS in comparison to typically developing controls. AD was lower in bilateral regions of the anterior portion of the cingulum bundle, IFO, ILF, and SLF. Also, compared to controls, 22q11DS participants had lower AD in the left uncinate fasciculus and the splenium and genu of the corpus callosum. The greatest effect sizes were observed for AD in the SLF (partial η*^2^* for right and left = 0.40; see Supplementary Table [S3](#SM1){ref-type="supplementary-material"}). RD in the splenium of the corpus callosum and bilateral regions of the ILF and SLF was significantly reduced in 22q11DS in comparison to typically developing controls. AD and RD results are shown in Figures [4A,B](#F4){ref-type="fig"}, respectively.

![**Group differences between individuals with 22q11DS versus typically developing controls on measures of **(A)** axial diffusivity (AD) and **(B)** radial diffusivity (RD).** AD and RD values are marginal means adjusted for covariates of scanner site, age, and gender. \**q* \< 0.05.](fnbeh-08-00393-g004){#F4}

All regions that showed significant FA or AD differences remained statistically significant (*p* \< 0.05) or approached significance (*p*≤ 0.10) when the total sample was broken into subgroups according to scanner location (BMC, CCN). For measures of RD, differences in the primary tract of the right SLF remained statistically significant (*p* ≤ 0.05) and approached significance in the temporal portion of the SLF (*p* ≤ 0.07) when the sample was divided into sub-groups according to scanner. However, for all other measures of RD that were statistically significant when the whole group was examined (i.e., splenium of corpus callosum, left and right ILF, left SLF) these results only remained statistically significant when comparing 22q11DS vs. controls in the BMC scanner subgroup. Results are presented in Supplementary Table [S4](#SM1){ref-type="supplementary-material"}.

AGE × DIAGNOSIS INTERACTIONS
----------------------------

There were significant age^∗^group interactions for left ILF FA \[*F*(5,59) = 4.2, *p* = 0.04\] and RD \[*F*(5,59) = 5.8, *p* = 0.02; **Figure [5](#F5){ref-type="fig"}**\]. In controls, ILF FA values increased with increasing age (*r* = 0.52, *q* = 0.03). However, this relationship was not present in 22q11DS participants (*r* = 0.06, *q* = 0.90). In the left ILF, controls showed decreasing RD with increasing age (*r* = -0.62, *q* = 0.02), but again, this pattern was not seen in 22q11DS (*r* = -0.08, *q* = 0.85). Of note, we did not find a significant relationship with age and psychotic symptoms in 22q11DS (*r* = 0.19, *p* = 0.30).

![**Patterns of age-associated changes in **(A)** fractional anisotropy (FA) and **(B)** radial diffusivity (RD) in 22q11DS participants versus typically developing controls in the left inferior longitudinal fasciculus (ILF).** Controls show the expected pattern of increased FA and decreased RD with increasing age, which is not observed in 22q11DS patients \[*F*(5,59) = 4.2, *p* = 0.04 and *F*(5,59) = 5.8, *p* = 0.02, respectively\].](fnbeh-08-00393-g005){#F5}

RELATIONSHIPS BETWEEN DTI INDICES AND POSITIVE SYMPTOMS IN 22q11DS
------------------------------------------------------------------

Significant relationships were observed between AD in the IFO bilaterally and positive symptoms in 22q11DS (left: *r* = -0.53, *q* = 0.008, right: *r* = -0.49, *q* = 0.02, **Figure [6](#F6){ref-type="fig"}**). In both regions, decreased AD was associated with greater severity of positive symptoms. There were no relationships between FA and RD and positive symptoms in 22q11DS. When effects of IQ were regressed out, and the significant correlations were re-run, all correlations remained significant (Supplementary Table [S5A](#SM1){ref-type="supplementary-material"}).

![**Relationship between total positive symptoms and axial diffusivity (AD) in the **(A)** left inferior longitudinal fasiculus (IFO) and **(B)** right IFO in 22q11DS participants.** As AD in the left and right IFO decreases, positive symptom severity increases.](fnbeh-08-00393-g006){#F6}

RELATIONSHIPS OF DTI INDICES WITH SOCIAL COGNITION
--------------------------------------------------

As seen in **Figure [7](#F7){ref-type="fig"}**, increased AD in the left IFO (22q11DS: *r* = 0.53, *q* = 0.008; controls: *r* = 0.46, *q* = 0.04) and left uncinate fasciculus (22q11DS: *r* = 0.57, *q* = 0.004, controls: *r* = 0.47, *q* = 0.04) was associated with better performance on the TASIT in both 22q11DS participants and controls. A similar pattern of results was observed for the relationship between ER40 performance and the left IFO (*r* = 0.47, *q* = 0.02) and left uncinate fasciculus (*r* = 0.45, *q* = 0.03) in 22q11DS, but not in controls (left IFO: *r* = 0.11, *q* = 0.8, left uncinate fasciculus: *r* = -0.07, *q* = 0.8). Controls also showed a significant associations between increased AD in the SLF bilaterally (left SLF: *r* = 0.59, *q* = 0.008; right SLF: *r* = 0.61, *q* = 0.008) and ILF bilaterally (left ILF: *r* = 0.55, *q* = 0.02; right ILF: *r* = 0.47, *q* = 0.04) with better social cognition performance on the TASIT. However, relationships between SLF and ILF AD and TASIT performance were not observed in 22q11DS participants (all *q* \> 0.7). When effects of IQ were regressed out, and the significant correlations were re-run, all correlations remained significant for both 22q11DS participants and controls, aside from relationships between social cognition performance and the ILF regions for controls (Supplementary Tables [S5B,C](#SM1){ref-type="supplementary-material"}).

![**Relationship between social cognition performance and AD in the **(A)** left IFO and **(B)** left uncinate fasciculus (UNC).** In both 22q11DS participants and controls, as AD in the left IFO and UNC increases, social cognition task performance improves.](fnbeh-08-00393-g007){#F7}

We conducted secondary analyses of AD measures in the left IFO and left uncinate fasciculus (the only regions that showed a significant relationship with overall ER40 performance) and task performance for specific emotions in 22q11DS. These results indicate that the only emotion that significantly correlated with these two measures was fear, with better recognition of fear associated with increased AD in both regions in 22q11DS (left IFO: *r* = 0.46, *p* = 0.005; left uncinate fasciculus: *r* = 0.38, *p* = 0.02).

STRENGTH OF LINEAR RELATIONSHIPS BETWEEN MEASURES OF AXIAL AND RADIAL DIFFUSIVITY
---------------------------------------------------------------------------------

Results of these analyses in 22q11DS patients and controls are presented in **Table [2](#T2){ref-type="table"}**. Compared to controls, 22q11DS participants showed a significantly stronger linear relationship between AD and RD in the right cingulum bundle (Z = 2.84, *q* = 0.03), the genu (*Z* = 3.2, *q* = 0.01), and the right uncinate fasciculus (*Z* = 2.76, *q* = 0.03). 22q11DS showed significant positive relationships between RD and AD in the right ATR, bilateral regions of the IFO, the right SLF, left uncinate fasciculus, but controls did not show significant relationships in these regions. However, compared to controls, 22q11DS patients did not show a statistically stronger linear relationship in these regions. We found that both controls and patients showed significant positive linear relationships between RD and AD in the left ATR and left cingulum bundle in the hippocampal region. In all cases where there was a linear relationship between AD and RD, increased AD was associated with increased RD.

###### 

Correlations between axial and radial diffusivity (RD) for ROIs within white matter tracts and Fisher *r*-to-*Z* transformation results comparing the correlations of participants with 22q11.2 deletion syndrome versus typically developing controls.

  -----------------------------------------------------------------------------------------------------------------------------------
  Region                                                     Correlations    Fisher *r*-to-*Z* transformation              
  ---------------------------------------------------------- --------------- ---------------------------------- ---------- ----------
  Left anterior thalamic radiations                          *r* = 0.75\     *r* = 0.57\                        1.24       0.41
                                                             *q* = 9.1e-6    *q* = 0.01                                    

  Right anterior thalamic radiations                         *r* = 0.70\     *r* = 0.46\                        1.41       0.35
                                                             *q* = 0.00007   *q* = 0.06                                    

  Left corticospinal tracts                                  *r* = -0.10     *r* = 0.62                         -2.38      0.07

                                                             *q* = 0.81      *q* = .007                                    

  Right corticospinal tracts                                 *r* = 0.19      *r* = 0.49                         -1.31      0.39

                                                             *q* = 0.48      *q* = 0.03                                    

  Left anterior cingulum                                     *r* = -0.14\    *r* = -0.19\                       0.2        0.94
                                                             *q* = 0.65      *q* = 0.54                                    

  Right anterior cingulum                                    *r* = 0.06\     *r* = 0.11\                        -0.19      0.94
                                                             *q* = 0.88      *q* =0 .81                                    

  Left cingulum bundle\                                      *r* = 0.84\     *r* = 0.61\                        1.95       0.15
  (hippocampal region)                                       *q* = 1.8e-8    *q* = 0.008                                   

  Right cingulum bundle\                                     *r* = 0.86\     *r* = 0.50\                        **2.84**   **0.02**
  (hippocampal region)                                       *q* = 5.4e-9    *q* = 0.07                                    

  Splenium                                                   *r* = 0.27\     *r* = 0.02\                        0.98       0.55
                                                             *q* = 0.27      *q* = 0.97                                    

  Genu                                                       *r* = 0.74\     *r* = 0.11\                        **3.2**    **0.01**
                                                             *q* = 0.00001   *q* = 0.81                                    

  Left inferior longitudinal fasciculus                      *r* = 0.11\     *r* = 0.06\                        0.19       0.94
                                                             *q* = 0.81      *q* = 0.92                                    

  Right inferior longitudinal fasciculus                     *r* = -0.004\   *r* = -0.02\                       -0.06      0.99
                                                             *q* = 0.99      *q* = 0.97                                    

  Left inferior fronto-occipital fasciculus                  *r* = 0.63\     *r* = 0.31\                        1.6        0.26
                                                             *q* = 0.0009    *q* = 0.25                                    

  Right inferior fronto-occipital fasciculus                 *r* = 0.48\     *r* = 0.32\                        0.73       0.74
                                                             *q* = 0.02      *q* = 0.44                                    

  Left superior longitudinal fasciculus                      *r* = 0.37\     *r* = 0.37\                        0.0        1.0
                                                             *q* = 0.09      *q* = 0.12                                    

  Right superior longitudinal fasciculus                     *r* = 0.50\     *r* = 0.50\                        0.0        1.0
                                                             *q* = 0.02      *q* = 0.15                                    

  Left uncinate fasciculus                                   *r* = 0.45\     *r* = 0.35\                        0.37       0.88
                                                             *q* = 0.03      *q* = 0.17                                    

  Right uncinate fasciculus                                  *r* = 0.51\     *r* = -0.16\                       **2.76**   **0.03**
                                                             *q* = 0.01      *q* = 0.66                                    

  Left superior longitudinal\                                *r* = 0.28\     *r* = 0.27\                        0.04       0.99
  fasciculus (temporal region)                               *q* = 0.24      *q* = 0.35                                    

  Right superior longitudinal fasciculus (temporal region)   *r* = 0.03\     *r* = -0.11\                       0.54       0.81
                                                             *q* = 0.94      *q* = 0.81                                    
  -----------------------------------------------------------------------------------------------------------------------------------

Values in bold show a statistically significant difference in the strength of the relationship between 22q11DS and controls.

DISCUSSION
==========

This study used a whole brain and region of interest (ROI) approach to examine multiple DTI indices in 22q11DS, a neurogenetic disorder that confers significantly increased risk for the development of psychosis. Several findings emerged -- some novel, while others extend upon the small body of existing 22q11DS DTI literature: (1) in comparison to controls, 22q11DS participants had reduced AD, putatively indexing axonal damage ([@B116], [@B115]), in multiple white matter tracts, with the strongest effect sizes observed in the SLF, a fronto-parietal tract; (2) 22q11DS participants also exhibited decreased RD, a putative marker of neuroinflammation ([@B21]; [@B97]) in the splenium, SLF, and ILF; (3) there was a disrupted pattern of age-associated changes in FA and RD of the left ILF in 22q11DS, (4) increased AD in the left IFO and uncinate was associated with improved social cognition performance in both 22q11DS participants and controls, and (5) reduced AD in both the left and right IFO was associated with increased positive symptom severity in 22q11DS.

GROUP DIFFERENCES: 22q11DS VS. TYPICALLY DEVELOPING CONTROLS
------------------------------------------------------------

In line with prior, smaller studies we found decreased AD, a putative index of axonal disruption ([@B115]), in multiple tracts in 22q11DS. [@B91] also found widespread decreases in AD, including the IFO and SLF. Another group found decreased AD in the left hemisphere in 22q11DS patients relative to controls in a region that included the intersection of IFO, ILF, SLF, cingulum, and anterior thalamic radiations (ATR; [@B52]). Using DTI tractography, this group also identified reduced AD in the IFO and ILF in 22q11DS participants ([@B53]). Murine models resulting in axonal degeneration or axonal damage and/or loss have observed decreased AD ([@B115]; [@B13]). Other studies in animal models have found that reduced diameter of axonal bundles is also associated with reduced AD ([@B104]; [@B41]). Thus, the reduced AD observed in 22q11DS may reflect reduced diameter of axonal bundles, axonal degeneration, damage, and/or loss. To our knowledge, however, white matter microstructure has not been directly investigated in mouse models of 22q11DS.

It is important to note that axonal damage does not occur in isolation. [@B115] found that degradation to the myelin sheath occurred *after* axonal degeneration, and [@B41] used a transgenic mouse that expressed a virus in oligodendrocytes, also resulting in oligodendrocyte apoptosis and demyelination (in addition to decreased axonal diameter). Supporting these findings, we found that measures of AD and RD were significantly related to each other in multiple regions, in both 22q11DS patients and controls.

Surprisingly, in both our ROI and whole-brain analyses, we also found decreased RD in 22q11DS, which was not observed in two prior 22q11DS studies that examined specific sub-components of FA ([@B52]; [@B91]). However, more recently, [@B82] used white matter tractography to examine three tracts of interest (i.e., ALIC, fornix, and uncinate) and found that decreased RD drove the observed increases in FA in bilateral regions of the ALIC in 22q11DS. Recent studies in human populations have found decreased RD to be associated with neuroinflammation, as decreased RD in multiple brain regions has been found in individuals with autoimmune disease ([@B21]) and history of concussion ([@B97]). Decreased RD has also been observed in a rodent model of thrombotic stroke (induced by hypoxia-ischemia); in this study, decreased RD correlated with swelling of myelin sheaths ([@B110]). Upon further investigation, the authors found that cerebral hypoxia-ischemia rapidly induced oxidative stress in oligodendrocytes, resulting in swelling of myelin and compression of axoplasma ([@B110]). Others have found that smaller axonal diameter was associated with decreased RD in the corpus callosum of the rat brain ([@B5]). On the other hand, increased RD has been observed in shiverer mice, who have thin, loosely packed, or absent myelin sheaths, but intact axonal integrity ([@B116]). Similarly, a cuprizone mouse model, which results in oligodendrocyte loss followed by demyelination, also showed increased RD ([@B117]). Thus, the significant decreases in RD that we observed in human subjects with 22q11DS could potentially reflect swelling of myelin sheaths and/or compression of axoplasma, reduced axonal diameter, and/or increased myelination.

In our whole-brain analyses, those with 22q11DS had higher FA in several regions, including the posterior limb of the internal capsule, the corona radiata, the body of the corpus callosum, and a small region of the left SLF. These findings are unexpected, given that the majority of DTI studies to date have found decreased FA in 22q11DS patients (e.g., [@B7]; [@B119]; [@B91]; [@B125]). However, our findings do replicate increases in FA previously observed in 22q11DS in the corona radiata ([@B119]) and SLF ([@B112]). Additionally, somewhat consistent with our findings of increased FA in the body of the corpus callosum, [@B7] found increased FA in the genu and the splenium of the corpus callosum in 22q11DS. Furthermore, the findings of increased FA in 22q11DS are consistent with evidence from other neurogenetic syndromes involving anomalous neurodevelopment, i.e., William's syndrome, ([@B43]; [@B2]; [@B40]).

Although the cellular mechanisms underlying increased FA in 22q11DS in these regions are unknown, our findings were likely driven by a combination of decreased AD and RD. Regional increases in FA in children with other neurodevelopmental disorders has been observed, and the authors of these studies have offered a number of speculations as to causal mechanisms at the cellular level, such as: decreases in axonal branching ([@B43]), fewer obliquely oriented fibers ([@B18]), flattened fibers, enabling the increased density of white matter ([@B12]), or decreases in fiber crossing ([@B2]). Genes located within the 22q11 locus, such as the Reticulon 4 receptor gene (RTN4R), which is associated with axonal growth inhibition ([@B28]), may contribute to white matter microstructural abnormalities in 22q11DS. However, given that, to our knowledge, no mouse models of 22q11DS have examined white matter pathology, the precise contributing cellular mechanisms remain unknown.

In contrast, our ROI analyses did not indicate higher FA in 22q11DS participants relative to controls within the tracts investigated. The ROI approach, which averages all the voxels within a specific region, may have masked the increased FA identified in specific tracts (i.e., posterior limb of the internal capsule, superior and posterior corona radiate, body of the corpus callosum, small portion of the left SLF) in the whole-brain approach. For example, the SLF is a large ROI and the small portion of increased FA that we identified in the whole-brain analysis could have been obscured when the average FA was calculated for that ROI. Additionally, the ROIs used in this study did not cover the entire mean skeleton obtained (e.g., the body of the corpus callosum was not an identified ROI), and thus such regions were not included in the ROI analyses. However, despite the lack of significantly increased FA in the ROI analyses, we did find decreased AD and RD in regions that produced comparable results to the whole brain findings. These findings also highlight the importance of using separate measures of diffusivity to examine white matter abnormalities in patient groups, as in other brain disorders ([@B77]).

Although the number of published DWI studies in 22q11DS is small (11 publications as of June 2014), the findings have varied, due in part to the methodological differences and sample characteristics. For example, many of the studies did not align the *b*0 image to a T1-weighted structural scan to correct for EPI induced artifacts, which result in spatial distortions that could substantially change the results. Another reason for these discrepant findings may be due to difficulties encountered when registering DWI data ([@B114]), particularly when the shape of tracts differs between groups. Though the optimal type of registration is not agreed upon ([@B114]; [@B103]), differences in registration methods used can also result in substantially different results. Furthermore, customization of ROIs may help in obtaining accurate results in clinical populations, particularly those with neurogenetic conditions. For example, editing the ROIs obtained from the Johns Hopkins University atlas to fit our mean skeleton was necessary for proper placement of the ROIs entirely within white matter. Thus, we suggest that future studies investigate how the selected ROIs map onto one's data prior to running analyses, and adjust the ROIs if necessary. To our knowledge, this is not standard practice in DTI studies, but has been performed in published manuscripts by our collaborators ([@B47]).

AGE ASSOCIATED DISRUPTIONS IN WHITE MATTER MICROSTRUCTURE IN 22q11DS
--------------------------------------------------------------------

We also found age-related disruptions in white matter microstructure of the left ILF in those with 22q11DS, as 22q11DS participants failed to show the age-associated increases in FA observed in typically developing controls. Notably, a similar finding has been observed in youth at CHR for psychosis, who failed to show typical age-related FA increases in the medial temporal lobe ([@B47]). Our finding appears to be driven by an age-associated disruption of RD in the ILF of 22q11DS participants. Typically developing adolescents show decreases in RD as they age, which is believed to reflect increased myelination ([@B3]; [@B111]); however, our results suggest that 22q11DS participants do not show this pattern of decreasing RD with age. Although the age^∗^group interaction only reached significance within this tract, several other regions, including the SLF, appeared to follow a similar pattern, and these results approached significance. There may be an atypical neurodevelopmental trajectory of white matter microstructure in 22q11DS; one hypothesis is that those with 22q11DS undergo "precocious maturation," with myelination occurring before the period of adolescence, closing the window for heightened brain plasticity during adolescence and young adulthood. This pattern of increased early myelination has been observed in mice who underwent early life stress (i.e., being weaned from their mothers at an early age ([@B78]; [@B54]). Notably, like patients with 2q211DS, these mice displayed increased anxious behaviors ([@B78]). Thus, 22q11DS participants may have "early" myelination, resulting in increased FA at an earlier age and failure to show the typical increase in adolescence and young adulthood. Equally plausible is the possibility of delayed myelination; for example, structural neuroanatomic studies of 22q11DS have found a pattern of delayed cortical maturation has been observed in children with attention deficit hyperactivity disorder ([@B109]). This possibility is consistent with a previous structural neuroimaging ([@B98]) study and a proton spectroscopy study ([@B107]) of 22q11DS participants. For example, FA may increase at a later age in those with 22q11DS relative to typically developing youth. However, these hypotheses need to be tested with prospective longitudinal investigations, which are currently in progress.

Additionally, the wide variability of findings in the 22q11DS literature may be at least partly due to developmental changes taking place on white matter microstructure. Development of white matter, particularly fronto-temporal and limbic connections, continues to take place during adolescence and young adulthood ([@B9]; [@B33]; [@B59]; [@B111]). Notably, white matter changes in adolescence parallel the development of cognitive and social-affective processes during this sensitive period ([@B10]; [@B19]), which may be relevant to the development of psychosis ([@B81]). The majority of previous DTI studies of 22q11DS did not covary for age when examining group differences ([@B7]; [@B112]; [@B91]; [@B53], [@B52]) and none of these studies examined how age-associated white matter changes may be disrupted in 22q11DS.

ASSOCIATION OF WHITE MATTER MICROSTRUCTURE WITH SOCIAL COGNITION PERFORMANCE IN 22q11DS AND CONTROLS
----------------------------------------------------------------------------------------------------

Greater axonal coherence (i.e., higher AD) in the IFO and uncinate was associated with improved social cognition in both 22q11DS patients and healthy controls. Similar results have been reported in a combined analysis of 22q11DS participants and controls: increased AD in the right hemisphere of the SLF, the posterior corona radiata, and IFO was related to better social skills (as measured by the socialization subdomain of the Vineland Adaptive Behavior Scales, [@B91]). The IFO is the longest association tract in the brain and has multiple connections between the occipital, temporal, and frontal lobes ([@B66]; [@B96]). It has been hypothesized that the IFO is crucial for integrating information between physically distant brain regions ([@B96]), which is essential for integrating social information from one's environment and responding appropriately. Furthermore, damage to the IFO results in impairment in emotion recognition ([@B85]), highlighting the important role that this tract plays in facilitating connections between visual processing and emotion-related cortical regions (i.e., visual cortex to orbitofrontal cortex).

To our knowledge, this study is the first to relate higher AD in fronto-limbic tracts (i.e., uncinate fasciculus) to better social cognition in both controls and 22q11DS participants. The uncinate connects the amygdala to the anterior temporal lobe and orbitofrontal cortex ([@B31]; [@B32]) and is believed to play a role in the interaction between emotion and cognition ([@B6]). This white matter tract has been associated with the following socially related functions: evaluation of stimuli, social reward processing, and higher-level emotional meaning of concepts (for a review, [@B126]). Thus, it is not surprising that we see that greater axonal coherence in this tract is associated with improved social cognition performance in both 22q11DS participants and controls.

ASSOCIATION OF WHITE MATTER MICROSTRUCTURE WITH POSITIVE SYMPTOMS IN 22q11DS
----------------------------------------------------------------------------

To our knowledge, this is the first study to relate positive symptoms and lower AD in 22q11DS. Importantly, decreased AD in bilateral IFO was related to increased positive symptom severity in 22q11DS, is consistent with the previously noted association between AD in the left IFO with improved social cognition performance in 22q11DS participants. In a prior behavioral study, the same social cognition task (i.e., TASIT) was the most significantly related to psychotic symptomatology in 22q11DS, when compared to other measures of social and non-social cognition ([@B44]). Disrupted axonal coherence in the IFO may underlie the social cognition impairment and psychotic symptoms in 22q11DS, suggesting a common mechanism of brain disturbance.

RELATIONSHIP OF FINDINGS TO IDIOPATHIC SCHIZOPHRENIA
----------------------------------------------------

Multiple studies in patients with idiopathic schizophrenia have consistently demonstrated that disruption in white matter microstructure in multiple regions is driven by increased radial, not axial, diffusivity, which authors interpret as indicating that white matter dysfunction in idiopathic schizophrenia is primarily driven by demyelination, rather than axonal damage ([@B105]; [@B63]; [@B60]). This hypothesis is supported by the post-mortem histopathology literature, which shows disturbances in the function and structure of oligodendrocytes, brain cells responsible for the myelination of axons ([@B23]; [@B128]). Thus, as postulated by [@B52], it is possible that white matter pathology associated with psychosis in 22qDS is driven by different neuropathological mechanisms relative to idiopathic psychosis. Nevertheless, such perturbations of structural connectivity between brain regions critical for social processing may lead to downstream commonalities in their phenotypic effects. Finally, these findings are not consistent with the majority of the idiopathic schizophrenia literature, other studies have found increased FA in white matter microstructure in other neurogenetic disorders, such as Williams' syndrome ([@B43]; [@B2]; [@B40]), which may be attributable to a decrease in normal amount of branching in these cortical tracts, leading to less fiber crossing and thus resulting in increased FA ([@B43]).

RELATIONSHIP OF FINDINGS TO EXISTING 22q11DS NEUROIMAGING LITERATURE
--------------------------------------------------------------------

This work complements the existing structural and functional neuroimaging work in 22q11DS. For example, structural abnormalities of the corpus callosum in 22q11DS have been detected in multiple studies([@B108], [@B106]; [@B4]), and we see white matter abnormalities in the corpus callosum (increased FA in the body of the corpus callosum, decreased RD and AD in the splenium, and decreased AD in the genu). However, to our knowledge, the relationship between white matter volumetric and DTI measures in 22q11DS has not yet been examined. Additionally, a combined structural and diffusion MRI study of 22q11DS found an overall global loss of connectivity (6%) in 22q11DS participants compared to controls ([@B80]), and another study of resting state functional connectivity showed deficits in long range connectivity in 22q11DS youth ([@B102]); these findings are consistent with the AD deficits seen in long range association tracts (i.e., ILF, IFO, SLF) that we observed in 22q11DS. Reduced frontal--temporal functional connectivity has also been observed in 22q11DS ([@B79]) and we observed reduced AD in the uncinate fasciculus, a frontal--medial temporal tract. In the future, it will be important to conduct studies that incorporate multiple neuroimaging modalities (e.g., DTI, fMRI) in 22q11DS to better understand how these findings inform each other.

The observed relationship between reduced AD and increased psychotic symptom severity in 22q11DS also extends upon the existing literature on relationships between neuroimaging measures and the psychosis phenotype in 22q11DS. Two recent studies have found white matter microstructure abnormalities in the cingulum bundle (increased FA and decreased RD), anterior limb of the internal capsule (increased right FA, decreased left RD), and uncinate fasciculus (decreased bilateral RD) have been associated with increased psychotic symptoms in 22q11DS ([@B50]; [@B82]). To our knowledge, ours is the first study to identify a significant relationship between decreased AD in bilateral regions of the IFO and increased psychotic symptom severity in 22q11DS. Taken together, these findings provide support for the notion that structural dysconnectivity is particularly relevant to the psychosis phenotype in 22q11DS. Furthermore, the relationships previously observed between decreased RD and psychotic symptoms in 22q11DS ([@B50]; [@B82]), paired with our findings of decreased RD in 22q11DS overall, suggest that decreased RD may also be pathological.

LIMITATIONS
-----------

Several limitations of this study should be noted. First, given our cross-sectional design we were unable to investigate changes in DTI measures over time as predictors of subsequent development of psychotic symptoms in 22q11DS. In the future, it will be critical to incorporate a longitudinal approach, as studies of structural neuroanatomic predictors of psychosis have found change over time to be a strong predictor of symptom development, in both 22q11DS ([@B49]) and idiopathic psychosis ([@B118]; [@B122]). Secondly, established DTI measures may not be equipped to measure the complexity of increased fiber crossing that is hypothesized to occur as one ages ([@B92]). One specific drawback to this methodology is that, within one voxel, only one primary direction of diffusion can be calculated, despite the fact that there are many axons within a voxel ([@B8]; [@B86]). For example, in a region that has many different fibers crossing in different directions, the mean of the primary direction is calculated, which may result in a pattern of globally reduced FA in this region, even if FA is high in these different crossing fibers. Thus, it is possible that with increasing age controls are developing a more complex pattern of fiber crossing than those with 22q11DS. However, the limitations in scan resolution make it difficult to test this hypothesis. Other types of methodologies, such as q-ball imaging, measure diffusion without making assumptions about the underlying white matter microstructure ([@B124]). However, this imaging technique prolongs scan time, which is not always feasible for clinical populations. Therefore, advanced DTI techniques to quantify the complexity of fiber crossing are currently in development ([@B92]). Finally, scans were conducted on two different scanners; although these scanners were identical (Siemens 3 Tesla Tim Trio) and the proportion of patients and controls was similar across scanners, we nevertheless observed significant differences as a function of scanner location (Supplementary Table [S2](#SM1){ref-type="supplementary-material"}). Nevertheless, these differences were systematic and consistent across regions, as FA was consistently higher on one scanner, whereas AD and RD were consistently lower on this scanner. Thus, we covaried for scanner site in all analyses.

FUTURE DIRECTIONS
-----------------

The current study sets a foundation to develop future multi-modal neuroimaging biomarker studies in 22q11DS. The white matter pathways that we found to be associated with social cognition and psychosis (i.e., IFO) connect to a gray matter region, the medial orbitofrontal cortex, variation in which we have also found to be associated with psychosis in 22q11DS ([@B45]). Thus, to better understand how neuropathophysiological mechanisms are related to both social impairment and psychotic symptoms in 22q11DS, it will be important to examine relationships between measures of structural white matter connectivity and gray matter thickness, and in turn, how these measures relate to behavior, in both healthy individuals and those with 22q11DS. Furthermore, future investigations in larger samples of white matter microstructure in 22q11DS in relation to genetic pathways will be particularly informative given that multiple genes within the deleted region are associated with neuronal development ([@B67]). Specifically, well-validated bioinformatics approaches ([@B131]) have been developed, allowing us to identify pathways or modules of gene expression related to psychosis in 22q11DS patients, and relate these molecular features to neuroimaging and clinical data, thus connecting genes to brain to behavior, and setting up future studies to more thoroughly assess causality and mechanism both in humans and in animal models.
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